Toxoplasmic Encephalitis in Patients With AIDS. Treatment and Prevention of Relapse

Not Applicable

Completed

• Conditions: Toxoplasmosis, Cerebral; HIV Infections

• Registration Number: NCT00002064
• Lead Sponsor: Palo Alto Medical Foundation

Brief Summary

To compare pyrimethamine and intravenous (IV) clindamycin vs. pyrimethamine and sulfonamides in the treatment of AIDS patients with central nervous system (CNS) Toxoplasma gondii.

Detailed Description

Not available

Study Timeline

• Status Verified: 1989-06
• Study First Submitted: 1999-11-02
• Study First Submitted QC: 2001-08-30
• Study First Posted: 2001-08-31
• Last Update Submitted: 2005-06-23
• Last Update Posted: 2005-06-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Palo Alto Med Foundation; 🇺🇸 Palo Alto, California, United States